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ABSTRACT
OPTIMAL ALLOCATION OF BLOOD PRODUCTS
by
Godson A. Tetteh
The high cost of collection and the short shelf life of apheresis platelets demand efficient
inventory management to reduce outdates and shortages. Apheresis platelets are licensed
for seven days, and blood centers are keen on knowing the consequences of various
product collection and distribution strategies. To reduce outdates, inventory managers
typically distribute the older units first, thereby following first-in first-out (FIFO) policy;
however, hospital blood banks would prefer that the blood center issues out the freshest
units first, equivalent to a last-in first-out (LIFO) policy. This study addresses the optimal
distribution policy to achieve a desired outdate, shortage and average age of apheresis
platelets.
A comprehensive literature review was conducted on previous models studied to
efficiently distribute blood products. However, most of the research on blood inventory
management has been restricted to the hospital blood bank level in terms of ordering
policies and inventory levels. This study takes the approach from the perspective of the
inventory manager at the regional blood center. The inventory manager needs a reliable
forecast of the quantity and timing of future blood supply (collection from donors) and
blood demand from hospital blood banks to make an effective decision on blood
inventory control. A forecasting method is used in this study to predict collection and
demand for Single Donor Platelets (SDPs), and solves the blood inventory problem using
a heuristic method and a Linear Programming (LP) with a rolling horizon method to find
the near optimal issuing policy, the expected average age, outdate rate, and shortage rate
of a blood product from the perspective of the blood center.
It is concluded that regional blood centers can distribute with a 'mixed'
FIFO/LIFO strategy and not significantly affect outdates or ability to cover shortages. For
the LP model with a rolling horizon schedule, the inventory manager at the blood center
would have to use forecast windows of five to achieve good issuing policies.
A simulation study comparing the heuristic method and an LP-based with a
rolling horizon method indicated that LP models with forecast windows of five and
heuristics methods with a 'mixed' FIFO/LIFO strategy can be used to optimize this
inventory problem.
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CHAPTER 1
INTRODUCTION
"For the life of the flesh is in the blood" (Leviticus 17:11) - a quotation from the Bible
stresses the importance of human blood.
1.1 Background
Blood transfusion therapy is an important aspect of the medical care system, and it has
been stated that "one in three infants, teens, and adults of all ages will need blood
transfusion at one point of their life" 1 . In the New York metropolitan area, about 4000
newborn babies, trauma victims, cancer patients, transplant patients, and surgery patients
need blood transfusion each day. To meet this demand, blood collection centers and
hospital blood banks must maintain desirable inventory levels to ensure that blood
demand is adequately met and appropriate measures are taken to minimize blood waste.
Since human blood is a perishable product, there is a need for effective and efficient
management of the blood supply. To ensure effective use of the limited blood resources,
blood utilization and inventory management policies must be practiced by the blood
collection centers, hospital blood banks, and physicians ordering transfusions.
Blood products are supplied in the United States mainly by the American Red
Cross (ARC) and independent community blood centers that belong to America's Blood
Centers (ABC). The ARC, blood banks, and blood centers charge hospitals a service fee
to cover the costs for drawing, processing, testing, and distributing the blood. Blood
centers make strenuous efforts to recruit volunteer donors to replenish the blood supply.
It is important that every pint of blood donated should end up as a transfusable product.
1 See NYBC pamphlet "Donate Blood now. People can't live without it."
2The blood supply chain is made up mainly of blood donors, regional blood
centers, (community blood banks, or hospital blood bank donor rooms), hospital blood
banks, and patients at the hospital. The blood center or hospital blood bank donor room
collects blood in units of one pint from donors at a collection site. The collected blood
undergoes a series of typing and screening tests, is inventoried at the Blood Center or
Blood Bank, and then shipped to a hospital blood bank or transfusion facility at the
latter's request to satisfy present or expected demand for transfusions. Collection of
blood is an important function in the supply chain. Blood donations are collected by (1)
scheduled visits to organizations, schools, or churches where donors have already
pledged to give blood or telemarketers book platelet donors at scheduled times, (2) walk-
in donors to blood center's facilities, and (3) invited donors from a campaign. However,
an uncertain percentage of donors that pledge to donate blood may not be able to donate
due to health reasons, may defer their visit, or may not show up at all. Hence the amount
to be collected can only be estimated.
The primary blood products are whole blood, packed red blood cells, packed red
blood cells leukocytes reduced, fresh frozen plasma, plasma cryoprecipitate, and platelets
(apheresis and random). Packed red blood cells (RBCs), plasma, and random platelets
(RDP) may be extracted from a whole blood unit drawn from a donor and prepared by
centrifugal or gravitational separation.
Platelets are needed to support cancer therapy, treatment of blood disorders, organ
transplants, and open-heart surgery. Deficiencies in platelet number and function in a
patient may have unpredictable effects that may range from major life-threatening
hemorrhage to clinically insignificant prolongation of the bleeding time. Platelets are
3transfused to patients whose platelet count is much lower than the normal range of
150,000 - 400,000 per µL due to illnesses including cancer, leukemia, or certain blood
disorders. The platelet count criteria for transfusing platelets depends upon many factors
including but not limited to the clinical state of the patient and whether any invasive
procedures are going to be performed.
Apheresis platelets (SDPs) as well as random donor platelets (RDPs) have a
lifetime of five (or seven) days from collection depending on the technology used for
collection and the storage bag used. Apheresis platelets are a high-value product
compared to random platelets. Even though it is more expensive to obtain one unit of
SDPs than to prepare a random platelet from whole blood, SDPs can offer definite
advantages to recipients, including increased consistency of dose, decreased patient
exposure to disease transmission, speed of availability, and the possibility for matched
platelet transfusions (McLeod, Price and Weinstein, 2003).
Apheresis platelets account for about 60 percent of the total blood product sales of
a blood center. Because of their relatively high cost of collection and their short shelf-life,
the overall management of apheresis platelet collection programs can have substantial
consequences for a blood center and the hospitals that rely upon it. This dissertation
addresses some of the problems associated with the efficient allocation and inventory
management of apheresis platelets in a blood center.
41.2 Problem Statement
Forecasting blood demand (D) and collection (C) is a prerequisite for inventory control.
However, the uncertainty of the variable to be predicted is so high that standard
forecasting techniques lead to unsatisfactory results. Past data indicate that demand and
collection exhibit a lumpy pattern at certain times, and have both a trend and seasonality.
During holidays, many donors do not show up for blood drives. With this high degree of
uncertainty, some hospital blood banks tend to overstock their inventory towards the lean
season consequently creating a lumpy demand prior to a holiday. This "chaotic effect" of
historical demand tends to introduce large errors in the forecast and either over estimate
and increase the product outdate rate, or under estimate demand and create product
shortages.
Sometimes blood supplies to hospital blood banks are rationed during lean
seasons. This could skew the forecast if it was mainly based on past sales data instead of
actual demand. For example, blood centers may have an adequate record of sales, but if a
hospital requested a number of products that were not available, the blood center may
supply only a limited amount during these so called lean seasons. The negotiation
between the hospital and the blood center may not have been monitored, and as a result,
the record of sales could be a poor reflection of the actual demand.
Hospitals have contractual agreements for scheduled or 'standing order' deliveries
with the blood center to satisfy a hospital's demand. Most single donor platelet standing
orders however do not specify the ABO type distribution of the platelets but simply
specify the number of platelets.
5A hospital blood bank is concerned with maintaining a sufficient inventory of
platelets to meet variable daily demand of transfusions and reaches a working
compromise between the outdate and shortage rates. Sometimes supplemental or
`emergency' orders are made by the hospital blood bank for a specific type of blood
product when there is a shortage of that specific type. A typical break-down of an annual
order from blood banks indicated that 78 percent were of the standing orders and 22
percent were supplemental or emergency orders.
Since the blood supply is derived from volunteer donors, its collection and
availability is uncertain. Outdating a product is undesirable, but the uncertainties in
supply and demand can result in a number of blood products that exceed their shelf-life.
Due to the short shelf-life for Single Donor Platelets (SDPs), over-collecting on a
particular day could necessitate outdates, if the demand is less than the supply for that
period. It is also uncertain how many scheduled donors will actually show up and keep
their appointments. Since SDPs are produced by using automated cell-separator devices,
the system is constrained by the number of apheresis machines available. Each unit
collected is first tested for 2 days, and expires either 5 or 7 days after collection
depending on the type of storage bags used. A blood center must decide how many
platelet units to collect each day to satisfy demand for the period without outdating a
large fraction of the platelets.
To reduce outdates, the blood center would prefer to distribute the older units'
first thereby following first-in first-out (11140) policy. However, the hospital blood bank
ordering products would prefer that the blood center issues the freshest unit first and
follow a last-in first-out (LIFO) policy. As a matter of fact, there have been instances
6where hospital blood banks have insisted on a fresher product than that being offered by
the blood center. Hence the blood center cannot apply a strict use of the FIFO policy.
Single Donor Platelets (SDPs) used to expire on the fifth day following collection.
However, Gambro BCT was recently granted Food and Drug Administration (FDA)
permission to extend the shelf-life of SDPs from five to seven days following collection.
What will be the optimum issuing policy that will reduce outdate and shortage rates from
the perspective of the blood center? Who will benefit from the 7-Day platelet production
- the blood center or the blood banks? What will be the average age of the products
distributed by the blood center?
The primary objective of this dissertation is to address the following fundamental
inventory management problems for the optimum allocation of blood products with
special reference to Single Donor Platelets (SDPs):
1. Determine a forecasting method to predict Single Donor Platelets (SDP)
collection and demand.
2. Determine how the blood center can achieve its goal of fulfilling blood demand
and minimizing inventory costs by reducing outdates and shortages of platelets
(SDPs) using:
- A heuristic method using Microsoft Excel to obtain the optimal 'mixed'
FIFO/LIFO policy,
- A linear programming method using a rolling horizon schedule to obtain the
optimal policy,
- A stochastic model to compare the above two methods.
71.3 Dissertation Organization
This dissertation is organized into six chapters. The background, the inventory problem,
and the primary objectives are stated in the first chapter. A thorough literature review,
covered in Chapter 2, summarizes findings from previous studies on forecasting blood
supply and demand, blood inventory management, the linear programming method for
obtaining an optimal issuing policy, and rolling horizon schedule. Chapter 3 includes a
forecasting method to predict the collection and demand for Single Donor Platelets
(SDPs), and the verification of the forecasting method. In Chapter 4, the blood inventory
problem is solved using a heuristic and a Linear Programming (LP) with rolling horizon
method. The total benefit, expected average age, outdate rate, and shortage rate of a blood
product are obtained from the heuristic and the Linear Programming (LP) with rolling
horizon methods, and the results are evaluated. Chapter 5 contains a stochastic model to
compare the heuristic with the Linear Programming (LP) with rolling horizon methods,
and a discussion of the 5 - Day and 7 - Day inventory models. Conclusions and
recommendations for further studies are finally presented in Chapter 6.
CHAPTER 2
LITERATURE REVIEW
Most research on blood inventory management has been restricted to the hospital blood bank
level in terms of ordering policies and inventory levels.
This study focuses on inventory manager at level of a regional blood center which takes blood
orders from hospital blood banks. The literature review is classified into
(1) Forecasting blood supply and demand;
(2) Blood inventory management;
(3) Linear Programming to obtain an optimal issuing policy;
(4) Rolling horizon schedule.
2.1 Forecasting Blood Supply and Demand
A reliable forecast of the quantity and timing of future blood supply (collection from donors) and
blood demand from hospital blood banks is needed to manage inventory at the Regional Blood
Center and make an effective decision on blood inventory control. Forecasting blood supply and
demand can be based on quantitative approaches (for example, using historical data to predict the
future using regression or time series analysis) and qualitative approaches (using expert
judgment or management assumptions).
Frankfurter, Kendall, and Pegels (1974) used a short-term computerized blood inventory
level forecast and provided management the tool to control blood inventory levels by eliminating
blood shortages and excessive expirations. The forecasting model was made of blood transfusion
9forecasts using an exponential smoothing model (this method exponentially decreases weights of
past data); blood expiration forecasts using an exponential function with empirically derived
parameters; blood collection forecasts using historical data; and blood inventory projection based
on the transfusion forecast, predicted expirations, and forecasted collections.
Gardner Jr. (1979) tested the Box-Jenkins forecasting models (which uses a variable's
past behavior to select the best forecasting model from a general class of models including auto-
regressive, moving average, autoregressive-moving average (ARIMA) ), and multiple regression
models to forecast the aggregate number of blood tests to be conducted at a laboratory each
month as a function of time. He found that the regression models gave significantly better
forecast errors for both short and long range horizons. Pereira (2004) used three time-series
(namely autoregressive integrated moving average (ARIMA), the Holt-Winters family of
exponential smoothing models, and one neural-network-based) methods to investigate the
forecasting of demand for red blood cell transfusion.
Even though forecasting is a precondition for decision making in inventory practice, few
studies have focused on the interactions between forecasting and inventory decisions. Croton
(1972), Lee and Adam (1986), and Watson (1987) concluded that forecast errors can distort
projections of customer service in distribution inventories. Gardner Jr. (1990) in a study on the
impact of forecasting on inventory decisions in a large physical distribution system concluded
that the forecasting model choice is an important factor in determining the amount of investment
to support any target level of customer service. Analyzing the characteristics of the inventory
demand time series to identify alternative forecasting models, and the experimental design to test
forecasting models are relevant to the main topic of this dissertation.
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Time series forecast errors can be calculated using: Mean-Squared Error (MSE) which is
the absolute error that squares the difference between the actual historical data and the forecast
fitted data predicted by the model; Root Mean-Squared Error (RMSE) which is the average of
the absolute values of the forecast errors; Mean Absolute Deviation (MAD) which is an error
statistic that averages the absolute value of the difference between the actual historical data and
the forecast-fitted data predicted by the model; Mean Absolute Percent Error (MAPS) which is a
relative error statistic measured as an average percent error of the historical data points. Whybark
(1973) and Gardner Jr. (1990) in their experimental design to deal with outliers and jump shifts
in a time series forecasting system used control limits set at plus and minus three standard
deviations of demand, which is similar to a Shewhart (1939) control chart to determine when the
forecasting model will no longer be feasible. This procedure made marginal improvements in the
ability to forecast demand.
2.2 Blood Inventory Management
The optimal allocation of blood inventory could be described as a problem of finding an issuing
policy which either maximizes or minimizes a function of the inventory level and actions over
time. Optimal selection of an issuing policy with conditions under which either 1-4140 (first in,
first out) or LIFO (last in, first out) are used have generated a lot of interest especially with
perishable products like blood. Hospitals ordering blood products from blood banks or blood
centers insist on receiving the freshest blood product, thereby forcing the blood bank or center to
practice LIFO. In contrast, the blood bank or center will prefer to send out the older units first
(FIFO) to minimize outdate and shortage of blood products.
Derman and Klein (1958) formulated an optimal sequence to remove items from a
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stockpile of finite units of varying ages. The stockpile consisting of n items was associated with
the i-th item having an age (length of time in the stockpile) Si (1, n). The total field life (a
function L(S) of the age) of the stockpile depends on the sequence in which items are removed
from the stockpile, as an item was issued only when the previous item issued had expired.
They stated that if a complete knowledge of the function L(S) was available, then optimal
policies for any given situation could be obtained by a consideration of all n factorial (! )
different orderings and the consequent selection of the best, or the use of an algorithm would
lead to the solution. Derman and Klein in their study took the approach to specify conditions on
the "field life" of the item in the stockpile for which issuing either the oldest units first (FIFO) or
the newest units first (LIFO) was optimal. First-in-first-out (FIFO) and last-in-first-out (LIFO)
issuing policies in practice are the most easily understood and the most easily implemented
inventory policies, and only knowledge of the relative ages of the items in the inventory are
required. However, there are limitations to their study; (1) there was no penalty or installation
costs associated with the issuance of an item from the stockpile, (2) new items were never added
to the stockpile after the process started.
Pierskalla (1965) in a study on the analytic results of Derman and Klein (1958)
eliminated and modified some of the assumptions to obtain a LIFO or FIFO issuing optimal
policies. In perishable product inventory systems where the issuing of the stock to meet demand
was controlled by the consumer, the movement of units through the system was found to obey a
LIFO issuing policy (Cohen and Pekelman (1978)).
Brodheim et al. (1975) evaluated a class of inventory distribution policies for deliveries
of perishable products with variable demand, which was modeled as a Markov chain. Fries
(1975) and Nahmias (1982) determined independently the optimal ordering policy for a product
12
with a general lifetime of m periods by solving a dynamic programming equation. Chazan and
Gal (1977) used a similar approach to Cohen (1976), but daily demand was modeled as a discrete
random variable so that starting stock levels formed a discrete state space Markov chain.
Numerous theoretical models have been developed using dynamic programming models
(Prastacos, 1981), queuing models (Graves, 1982), and Markov chain models (Chazan and Gal,
1977), to solve the blood inventory problem. Simulation models (Cohen and Pierskalia, 1979)
have been used also to determine the operating characteristics curves and decision rules for
setting optimal blood inventory levels. Prastacos (1984) carried out a comprehensive review of
the theory and practice of blood inventory management and the models developed to address
some of the issues faced at the hospital levels, and stated that "because of the assumption that all
units demanded are used in these analytical research on general perishable products, the
analytical results obtained are not directly applicable to blood inventory management." Due to
this drawback blood bankers turned to empirically-obtained results in combination with their
own experience. Jennings (1968, 1973) used empirical results using data from a Massachusetts
hospital to derive the trade-off curves showing outdate vs. shortage as functions of the inventory
level.
Some of the recent studies on perishables include the use of an estimator for the
probability that an item will be sold in a period to determine the outdate and shortage operating
curves in an inventory problem with a fixed lifetime (Omosigho, 2002). Sirelson and Brodheim,
(1991) used a computer planning model for blood platelet production and distribution. Haijema
et al. (2007) in a study combined a Markov dynamic programming (MDP) and simulation
approach to optimize blood platelet production.
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2.3 A Linear Programming Method for Obtaining Optimal Issuing Policy
From the theoretical solution of Derman and Klein (1959), Linear Programming (LP) may be
one of the methods that may be useful in obtaining the optimal issuing policy. Linear
Programming (LP) deals with situations in which a function is to be optimized (for example,
maximize a benefit function, or minimize a cost function), where the objective function is linear,
and the constraints are linear equalities or inequalities.
Linear programming is an important field of optimization in operations research.
Historically, ideas from linear programming have inspired many of the central concepts of
optimization theory, such as duality, decomposition, and the importance of convexity and its
generalizations. A number of algorithms for other types of optimization problems work by
solving Linear Programming problems as sub-problems.
The main algorithm used in solving Linear Programming problems is the Simplex
method. Four major drawbacks (Schulze, 1998) of the simplex method are:
• Initialization, when there is a problem of finding the initial feasible solution with
which to start the simplex method;
• Iteration, when there may be difficulty in choosing an entering or leaving
variable;
• Degeneracy or Cycling could be encountered when the simplex method gets
"stuck" during iteration and finds itself repeating without changing the value of
the solution and therefore not changing the value of the objective function; and
• Termination, when the simplex method terminates by finding that the problem is
infeasible or unbounded or goes through endless, repeating sequences of non-
optimal solutions.
The importance of linear programming derives in part from its ability to be used in many
applications including agricultural economics (Kuang, 1972), solving the multi-commodity flow
problem (McBride, 1998), planning and scheduling in yogurt production (Entrup, Günther, Van
14
Beek, Grunow, and Seiler, 2005), inventory management, portfolio and finance management,
human and machine resource allocation, scheduling and transportation assignments. Likewise,
linear programming is heavily used in microeconomics and business management, either to
maximize the income or minimize the costs of a production scheme.
The main advantage of linear programming as an optimization method is that an optimal
solution is always found, if one exists.
2.4 Rolling Horizon Schedule
A rolling horizon schedule is the product of solving a finite horizon multi-period model and
implementing the first period's decision only. A period later, the multi-period model is updated
as relevant information is obtained and the process is repeated.
For the inventory manager to obtain the optimal issuing policy, he/she would have to
depend on forecasts for blood supply and demand into the future. However, forecasts further into
the future are prone to error. For multi-period problems like the inventory problem, decision(s)
for the first period or the first few periods are of importance to the decision maker.
Rolling horizon research dates back to the studies of Modigliani and Hohn (1955), and
Wagner and Whitin (1958). Forecasting and rolling horizon have been studied in dynamic
problems for inventory management, production planning, capacity expansion and warehousing
(Chand, Hsu, Sethi, 2002). Baker and Peterson (1979) found the longer the planning horizon the
better the rolling horizon performance of the static models.
Hence, one investigates given that the forecast window interval length has been
determined a priori, what impact the underestimate or overestimate of the blood supply and
demand would have on a rolling horizon inventory problem.
is
The next chapter explores a forecasting method to predict the collection and demand for
Single Donor Platelets (SDPs) and the verification of the forecasting method.
CHAPTER 3
FORECASTING PLATELET COLLECTION AND DEMAND
3.1 Overview
Forecasting platelet demand and collection is important for inventory control, but, the
uncertainty of the variable to be predicted is so high that standard forecasting techniques lead to
unsatisfactory results. Platelet donors are normally contacted by telephone or email and an
appointment is booked for a particular day of donation. Even though there are 'walk-ins' without
appointment, their number is insignificant.
Plateletpheresis is a process to obtain platelets from blood drawn from a single donor
(SDP) using a blood cell separator. Apheresis, which is the use of automated cell-separator
devices, may be described as a process by which blood is removed from a subject and is
continuously separated into layers. The desired component is retained, while the remainder is
returned to the donor. After the donation, the hematology laboratory receives the '
platelet-rich-plasma' samples from the platelet apheresis procedure to determine each product's platelet count
and concentration.2 The product of the volume and concentration will produce the 'yield'. The
hematology laboratory then informs the component laboratory of the availability of successful
"raw" products, indicating those that can be split into 'doubles' or 'triples'. After splitting, the
product volumes are determined by weighing each split product and the platelet count is
measured to obtain the qualified single donor platelet products, which will now be known as the
released product R,.
2 New York Blood Center-SOP, "Daily Quality Control Procedures for Single Donor Platelets Collected by Apheresis"
04.0048 July 2003
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3.2 Choice of Forecasting Method
The dataset comprises observations for SDP appointments and production in the New York/ New
Jersey region for a period of 12 months. To get an idea of the sample properties, Figure 3.01
graphically depicts Days to Donation, d, and the corresponding number of SDP appointments, A,
for a particular day of the week from the historical data.
Days Before Donation
Figure 3.1 Days to donation vs. number of appointments.
To gain some insight, the graphs in Figure 3.1 show that there are differences in the
filling rate of the appointments depending on the day of the week (for example, Sundays (Sun)
are the lowest filling rate).
A fitted line plot using a linear regression model for all days of the week had a p-value <
0.0005 which indicated a good fit to the data. A visual inspection of the plot revealed that the
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data were randomly spread about the regression line, implying no systematic lack-of-fit. This
provided some preliminary evidence for a linear relationship between the Days to Donation, d,
and the corresponding number of SDP appointments, A. Secondly, the mean SDP Appointments
in January were statistically similar with the mean SDP appointments in all other months as
depicted in Figure 3.2.
Boxplots of Jan - Dec
(means are indicated by solid circles)
Figure 3.2 Box plots comparing monthly SDP appointments.
The one way analysis of variance (ANOVA) test with the null hypothesis that there were
no differences among the mean SDP appointments, and the alternative hypothesis that there were
differences in the mean SDP appointments had ,a p-value of 0.992. Hence, the mean SDP
appointments in January are equivalent to the mean SDP appointments in all the months.
Based on the historical data analysis, it was assumed that blood supply (collection and
production) was stable and similar throughout the year. A similar analysis of blood demand from
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historical data exhibited the same characteristics, hence demand was assumed to be constant
throughout the year. Some of the observed factors that affected blood supply (collection) were
1. The inventory manager had limited control of the blood supply (collection) by
shifting blood donors from days the appointments are over-booked to days that
are under-booked based on a forecast.
2. Location and population of the blood drive.
Future studies could investigate how the limited control strategies of the inventory
manager affect blood supply (collection) and demand. This study assumed that blood supply and
demand are constant throughout the year based on the historical data analysis. Other prediction
models could be used if blood supply and demand is not uniform.
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(3.1)
3.3 Empirical Study Design and Methodology
The standard bivariate (two variables) linear regression model can be represented as follows:
A = β0 +β1d+ε
where A is the number of appointments for day t, /10 is the intercept, 	 is the slope, d is the
days to donation, and E is the error term. The regression results are shown in Figure 3.3.
Number of Appointments = 216 - 7.18*Days to Donation
Predictor 	 Coef 3 	SE Coef4 	T5	 P6
Constant 	 216.139 	 2.359 	 91.63 0.000
-7.1805 	 0.2018 	 -35.59 0.000
S7 = 5.599 	 R-Sq8 = 98.5% R-Sq9 (adj) = 98.4%
Analysis of Variance
Source 	 DF10 SS11 ms 12 F13	 /314
Regression 	 1 	 39701 39701 1266.54 0.000
Residual Error 19 	 596 	 31
Figure 3.3 Regression results from MINITAB.
3 This is the coefficient in a regression equation. Coefficients are the estimates of the parameters in a regression
equation. The coefficients are used, along with the independent variables, to calculate the fitted value of the
dependent variable.
4 Standard Error Coefficient
5 T statistic
6 P-values are often used in hypothesis tests, where you either reject or fail to reject a null hypothesis. The p-value
represents the probability of making a Type 1 error, which is rejecting the null hypothesis when it is true. The
smaller the p-value, the smaller is the probability that you would be making a mistake by rejecting the null
hypothesis.
7 This is the estimated standard deviation about the regression line.
8 This is Root Square, also called the coefficient of determination.
9 This is Root Square adjusted for degrees of freedom.
to Degrees of Freedom
Sum of Squares
12 Mean of Squares
13 F-test. An F-test is usually a ratio of two numbers, where each number estimate$, a variance. An F-test is used in
the test of equality of two populations. An F-test is also used in analysis of variance, where it tests the hypothesis of
equality of means for two or more groups. For instance, in an ANOVA test, the F statistic is usually a ratio of the
Mean Square for the effect of interest and Mean Square error. The F-statistic is very large when MS for the factor is
much larger than the Mean Square for error. In such cases, reject the null hypothesis that group means are equal. The
p-value helps to determine statistical significance of the F-statistic.
14 P-value
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The estimator of the parameters { 130 , 161 ) of the best fitting line of the regression model is the
least squares (LS) line which minimizes the sum of squared errors function Et of .
Based on historical data, a regression equation for SDP appointments 15 for days before
the scheduled date of donation was established. The regression equation generates Projected
Appointment Forecast. To calculate the Released Forecast 16 , the Projected Appointment Forecast
was multiplied by the Product per Appointment (PPA) 17 . The Product per Appointment (PPA)
value was obtained from past data by evaluating the current or known number of appointments
and the number of products released after laboratory testing.
The p-value (<0.0005) in the Analysis of Variance in Figure 3.3, indicates that the
relationship between the d (predictor) and A is statistically significant at an a -level of 0.05. This
is also shown by the p-value for the estimated coefficient of d, which is 0.0005. The R-square
value shows that d explains 98.4% of the variance in A, indicating that the model fits the data
extremely well.
3.4 Empirical Study Results
Regression equations for each day of the week were obtained as follows:
• Number of Appointment (Sundays) = 53.4113 - 1.4935*Days to Donation
• Number of Appointment (Mondays) = 186.896 - 7.44675 *Days to Donation
• Number of Appointment (Tuesdays) = 167.087 - 6.53247 *Days to Donation
15 SDP appointments with platelet donors are scheduled two weeks ahead of time.
16 Released forecast is the expected number of platelets to be released by the laboratory.
17 Product per appointment (PPA) is the ratio of the released product R t and the number of
donor appointments that produced the products.
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• Number of Appointment (Wednesdays) = 159.554 - 6.03636 *Days to Donation
• Number of Appointment (Thursdays) = 199.364 - 7.42208 *Days to Donation
• Number of Appointment (Fridays) = 219.398 - 8.87792 *Days to Donation
• Number of Appointment (Saturdays) = 216.139 — 7.18052 *Days to Donation
The regression equation for each day of the week was then used to obtain the Projected
Appointments. To calculate the Release Forecast, the Projected Appointment Forecast was
multiplied by the Product per appointment (PPA), which has to be further reduced by the non
hematology reject rate (which includes incomplete donations, contaminants, etc). The Sales
Forecast uses the moving average of the maximum and minimum value of sales from the
previous three weeks. The deviation between the actual variable and the forecast was monitored
and verified as indicated in section 3.5 below.
3.5 Verifying Empirical Study Results
Since forecasting is the act of predicting the future either based on historical data or speculation
about the future, there is a need to compare the forecasted value with the actual to determine if
the forecasting methodology is effective and efficient.
Shewhart (1939) developed a theory of statistical quality control and concluded that there
were two components to variations that were displayed in all processes. The first component
(common causes) that appeared to be inherent in the process was a steady component or had
random variation. The second component (special causes) was an intermittent deviation to
assignable causes and includes unusual events. When these unusual events are noticed and
proper action is taken to handle, the special causes can usually be removed or adjusted. Shewhart
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(1939) developed the standard control chart test based on three sigma limits to separate the
steady component of variation (common causes) from assignable causes (special causes).
Statistical Process Control (SPC) is made up of a set of tools and activities that help make
statistically valid decisions. A process is said to be in statistical control when special causes do
not exist. The SPC tools were used to verify if the aforementioned forecasting tool was efficient
in predicting SDP collection and demand. Control Charts are SPC tools used to help recognize
the presence of special causes or common causes in the process.
Control charts track the process by plotting data over time and see whether there are
within three standard deviations from the average. Normally one would desire at least 20 data
points. When a point falls outside these limits, the process is said to be out of control or the
process is unpredictable. When a process is in control/predictable, the control chart pattern
should exhibit "natural characteristics", a reflection of data randomness. To determine if a
process has special causes present, certain criteria will have to be met. A special cause is
assumed to be present if one or more of the following occurs:
• One point is more than 3 standard deviations from the center line,
• Nine points in a row are on the same side of the center line,
• Six points in a row are all increasing or all decreasing,
• Fourteen points in a row are alternating up and down,
• Two out of three points in a row are more than 2 standard deviations from the center line
(same side),
• Four out of five points in a row are more than 1 standard deviation from the center line
(same side),
• Fifteen points in a row are within 1 standard deviation of the center line (either side),
• Eight points in a row are more than 1 standard deviation from the center line (either side).
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For individual measurements like the variance for Quantity of Released Products, and
Demand (Sales), an I or X Chart is preferred. A moving range (MR) chart normally accompanies
these charts, hence the term I-MR or X-MR chart.
For an individual measurement control chart, the process average is the mean of the n
data points:
The adjacent values are used to determine the moving range (MR):
The average moving range (MR) is defined as
Charting parameter for the individual values are:
Upper Control Limit (UCL)
Lower Control Limit (LCL)
where the 2.66 factor is 31d2 — 3 since three standard deviations are used, and d2 makes a center
line correction and is obtained from the Table Constants for Control Charts in Appendix B.
Normal Probability Plot for Released Products
ML Estimates - 95% CI
25
Figure 3.4 Normal probability plot — forecasted released products.
Control Chart Test for Forecasted Released Products
Figure 3.5 Control chart test results — forecasted released products.
Control Chart Test for Forecasted Sales(Demand)
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Figure 3.6 Control chart test results — forecasted sales.
The forecasted value, actual value and deviation for Released SDP products and the demand' s
(Sales) are presented in Appendix A for analysis. The Normal Probability Plot of the variances
from the Released Forecast and Actual products released are depicted in Figure 3.4.
The example in Figure 3.4 shows points that form an approximately straight line, which
demonstrates that it was reasonable to assume that the data was from a normal distribution. To
determine if the forecast methodology was within process control as aforementioned, the
MINITAB statistical software was used, and the results are displayed in Figures 3.5 and 3.6. The
ImR computer plots shown in Figures 3.5 and 3.6 indicate no out-of-control or unpredictable
conditions for the forecasted released products and sales. Thus, there are no special causes.
However, the common causes or random nature characteristics are present and displayed by the
18 Sales assumed to be equal to demand for the purpose of this paper only.
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up-and-down swings. One could conclude that the methodology was appropriately predicting
quantity of SDP products to be released and sales (demand) for each period.
CHAPTER 4
BLOOD INVENTORY MANAGEMENT
4.1 Overview
Blood inventory managers are faced with the problem of meeting demand and at the same time
balancing the minimizing of outdates and the shortage of blood products. The relationship
between outdates and shortage of blood is a trade-off curve and a function of the inventory level.
If the quantity collected and released is increased, the outdate rate will increase and the shortage
rate will be reduced, and vice versa. Also, the blood center would have to decide whether to fill
daily demand with the older units first (FIFO policy) or to send the fresher units first (LIFO
policy). Most hospital blood banks insist on receiving the freshest unit in the inventory as the
efficacy of the blood unit decreases with time. However, if the blood center follows a strict LIFO
policy, the outdate rate will increase.
To illustrate the FIFO and LIFO issuing policies, suppose that a hospital orders 10 blood
units from the blood center having a total of 19 units with different expirations (3 expiring today,
5 with 1 day remaining before expiration, 5 with 2 days remaining before expiration, and 6 with
3 days remaining before expiration). The blood center following the FIFO policy will then ship
to the hospital 3 units expiring today, 5 units with 1 day remaining, and 2 units with 2 days
remaining. If the blood center in the above example is following the LIFO policy, it will ship 4
units with 2 days remaining on them, and 6 units with 3 days remaining. However, if the blood
center practices 50% FIFO and 50% LIFO, it will ship out 3 units expiring today, 2 units with 1
day remaining, and 5 units with 3 days remaining.
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4.2 Mathematical Model for Blood Inventory Management
The inventory network in Figure 4.1 below depicts released quantity R1 entering the inventory
system as (1,1); the Beginning Inventory is made of (1,1), (2,1), and (3,1) which is equivalent to
(j, t) where j = age of the unit, and t = day or period. (x1,1), (x2,1), (x3,1) are units moved from the
Beginning Inventory to fill Demand D 1 . The units that remain in the inventory y 3, will outdate
the next day (t+/).
Figure 4.1 Network representation of inventory problem.
To formulate the mathematical inventory model, assume R, amount of blood is released
on day t after testing to fulfill demand from a hospital blood bank.
Hospital demand Dt can be filled with the units in inventory yjt where j is the unit age (1,
2...7 for product expiring after age 7) at time t in days. There is a social benefit (WO for
fulfilling hospital demand Dt, a lost sale due to unfulfilled demand attracted a penalty (P), a
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holding cost (Hi) for the storage cost for carrying one unit of inventory for one time period, and
an outdate cost (0) for an expired unit. All these parameters are assumed to be deterministic.
4.3 Parameters
The parameters for the inventory problem are:
Rt 	 Quantity of blood product released into inventory on day t after laboratory testing,
Dt 	 Quantity of blood demand from hospital blood banks on day t,
Wj
	
Social benefit for satisfying demand with age-j product,
P 	 Penalty for not satisfying blood demand,
Holding cost for blood product at age j,
0 	 Outdate cost for an expired unit
The released units Rt enters the inventory at age 1 on day t as y1t. The quantity of units
moved from the inventory, yjt, at age j to fulfill demand, Dt at time t with a social benefit W3 are
represented by (xjt); and a lost sale, L t occurs when demand was not fulfilled with the current
inventory, yjt, with a penalty of P.
To solve the inventory problem two methods were employed:
(1) A heuristic method using Microsoft Excel with 'mixed' FIFO/LIFO policy,
(2) A Linear Programming (LP) method using the LINGO optimization software.
4.4 Heuristic Method using Microsoft Excel
A Microsoft Excel spreadsheet was set up for the heuristic method of the inventory problem as
indicated in Figure 4.2. To begin, the deterministic parameters social benefit (W i), holding cost
(Hi), lost sale penalty (Li), outdate cost (0), have to be entered. The Warning level or days
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indicate that the total beginning inventory is less than the average demand order and expressed as
a percentage, the issuing policy indicates the order percentages to be filled according LIFO and
FIFO issuing policy.
Figure 4.2 Heuristic method using Microsoft Excel.
Rows 21 to 23 in Figure 4.2 contain the headings in the spreadsheet which are: Day (cell
A23), Released Quantity (cell B23), Beginning Inventory with Ages 3, 4, 5 (cells C23-E23),
Demand (cell F23), FIFO Part % (cells G23-I23), LIFO Part % (cells L23-M23), After FIFO
(cells P23-R23), Ending Balance (cells S23-U23), Age of Products Shipped (cells V23-X23),
Average Age (cell Y23), Lost Sale (cell Z23), Outdate (cell AA23), Warning Days (cell AB 23).
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The Day column is filled through out for all periods. The Released Quantity represents
the aggregate platelets released which enters the Beginning Inventory as Age 3; ages 4 and 5 are
obtained from previous period ending balances. The demand (D i) is the aggregate demand from
the data given. For further details of the Microsoft excel spreadsheet formulation see Appendix
F.
4.5 Case Study I
A blood center must determine whether to send out the 'fresher' or 'older' single donor platelets
(SDP) first to meet daily demand of blood products. Assuming the revenue for filling one unit of
demand was $550; lost sales have a penalty of $550 per unit due to unrealized revenue and loss
of goodwill from customers, holding one unit in inventory will cost $10 per day, and a unit that
has expired costs $50. Assuming the SDP will expire after 5 days of collection and will take 2
days for laboratory testing (thus product shelf-life is 3 days). The objectives are:
(1) To determine how the blood center can maximize welfare (revenue less lost sale, outdate,
and holding cost) by fulfilling SDP demand using the released quantities Il i and demand
Di data provided for a period of 365 days and varying the issuing policy.
(2) To alert the blood center when the sum of units in inventory is less than 125% of the
average demand. Calculate the warning rate (defined as when the sum of the beginning
inventory is less than the anticipated demand), the outdate rate, and average age of SDPs
shipped to hospital blood banks.
4.5.1 Approach
To use the heuristic method with the Microsoft Excel spreadsheet formulation (Appendix F) and
data provided for the released quantities R t and demand D i, the issuing policy variable for the
141140 is changed from 0% to 100%. The total benefit, product outdate, age of product distributed,
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and days when the blood center inventory fell under a threshold (125% of average daily order)
are then tracked.
Table 4.3 Results of Case Study I
FIFO LIFO Total Benefit Warn Rate Avg Outdate Avg Age
0% 100% 28,533,675 45.2% 11.0% 3.15
10% 90% 29,461,512 43.0% 9.7% 3.22
20% 80% 30,131,751 40.3% 8.8% 3.28
30% 70% 30,666,105 30.7% 8.1% 3.37
40% 60% 31,239,333 20.0% 7.3% 3.50
50% 50% 31,673,266 12.3% 6.7% 3.65
60% 40% 31,864,459 6.9% 6.4% 3.80
70% 30% 32,012,946 4.1% 6.2% 3.98
80% 20% 32,093,711 0.8% 6.1% 4.18
90% 10% 32,094,483 0.6% 6.0% 4.38
100% 0% 32,095,210 0.3% 5.9% 4.58
The results for the Total Benefit, Warning Rate, Average Outdate Rate and Average Age
were as shown in Table 4.3. The maximum total benefit occurs at an issuing policy of 100
percent FIFO with a warning rate of 0.3 percent, outdate rate of 5.9 percent and an average age
of 4.58 days.
Figure 4.4 Effect of change in demand on outdates and shortages.
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Figure 4.4 shows the effect of change in demand on outdates and shortages. When demand was
varied from 85 to 115 percent of the current level the outdates declined from 20 to 0 percent. The
Low Inventory Warning Rate rose sharply after demand becomes 104 percent of the current level
as indicated in Figure 4.4 all being equal (ceteris paribus).
4.5.2 Limitation of the Heuristic Model
To operate the heuristic model, one needs to input the FIFO/LIFO policy, the released quantities
Rt and the demand D t for the entire period, T. The limitation to the heuristic model is that once
the FIFO/LIFO policy is specified, it will be carried throughout the entire inventory system
thereby achieving a near optimal allocation.
4.6 Linear Programming (LP) method using the LINGO optimization software
One other method of solving the inventory problem is Linear Programming (LP) - a tool for
solving optimization problems. Linear programming model components include decision
variables, model constraints and an objective function.
4.6.1 Decision Variables
The decision variables under one's control and influence are the total number of units (xt) moved
to fill demand, the left over (y e) in the inventory after fulfilling demand, and the lost sale (L i) due
to unfulfilled demand.
Yjt
	
Inventory level of blood product at age j at the end of day t
xit 	 Quantity of blood product at age j used to fill demand on day t
Lt 	 Quantity of unsatisfied blood demand on day t
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4.6.2 Constraints
Constraints on the values of the decision variables are as follows:
The sum of the units (zit) moved in the inventory to fill demand and lost sale Le are equal to the
demand. Hence
The ending inventory for t-1 should be equal to the sum of the inventory level of blood
product (ye) and the quantity of blood product used to fill demand (x jt) at age j (from j=2 to J) on
day t. Hence,
A unit released (Re) will enter the inventory at age 1. Therefore,
where j, the age of the blood product was 1 day old.
4.6.3 Objective Function
The blood center would like to maximize the total benefit (social benefit less holding cost, lost
sales cost and outdate cost). Hence the values of (x t), and (ye) that would generate the largest
value should be obtained. Letting z represent the value of the objective function,
The LP formulation can be written as
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The inventory problem is solved using the LINGO optimization software presented in Appendix
D, and the output is included in Appendix E.
4.7 Main Factors Effecting Inventory Model
The social benefit 	 holding cost Hi , lost sale cost P, and outdate cost 0, were parameters of
the inventory model which had assigned values. Hence there was a need to investigate the
sensitivity of the model to the values of these parameters.
Table 4.5 Factors with Levels for Design of Experiments (DOE)
Level 1 Level 2 Level 3
Benefit 500 640 675
Holding Cost 1 5 10
Lost Sale 600 3000 6000
Outdate Cost 4 250 450
The design of experiments (DOE) methodology was used to investigate the effect of
these parameters on the objective function. Three quantitative levels were chosen, each in
relation to the actual production costs to the four parameters or factors as indicated in Table 4.5.
A full factorial design was used with no replications producing 81 runs, the results of which are
included in Appendix G.
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Effect Tests
Source	 Nparm	 DF Sum of Squares	 F Ratio Prob > F
Benefit 	 2 	 2 	 3.83443e12 	 7615.509 	 <.0001
Holding cost 	 2 	 2 	 4051883337 	 8.0474 	 0.0010
Lost Sale 	 2 	 2 	 6.99211e12 	 13886.92 	 <0001
Outdate Cost 	 2 	 2 	 755255602 	 1.5000 	 0.2334
Benefit*Holding cost 	 4 	 4 	 1510518683 	 1.5000 	 0.2171
Benefit*Lost Sale 	 4 	 4 	 1510518683 	 1.5000 	 0.2171
Holding cost*Lost Sale 	 4 	 4 	 0.04938272 	 0.0000 	 1.0000
Benefit*Outdate Cost 	 4 	 4 	 755263082 	 0.7500 	 0.5629
Holding cost*Outdate Cost 	 4 	 4 	 1510511204 	 1.5000 	 0.2171
Lost Sale*Outdate Cost 	 4 	 4 	 1510511204 	 1.5000 	 0.2171
Figure 4.6 Analysis of variance (ANOVA) of factors.
When the model was run, the factors and their subgroup effects on the objective function
were analyzed using analysis of variance (ANOVA) techniques. The interaction effect was
considered to be statistically significant if its magnitude was large relative to the other column
effects. The JMP software was used to obtain the results shown in Figure 4.6. Figure 4.6
indicates that social benefit, holding cost, and lost sale, have p-values < 0.05 and therefore very
convincing significance of influence on the objective function. The ,factors' effect on the
objective function is shown in Figure 4.7.
Figure 4.7 Factors' effect on the objective function.
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The prediction profiler shows that the social benefit 	 and the lost sale cost P have a
significant influence on the objective function as indicated in Figure 4.7. The prediction profiler
gives a closer look at the best settings that produce the response target (objective function).
4.8 Rolling Horizon Schedule
So far it was assumed that the inventory manager needs to forecast the released quantity R t, the
daily demand D t, and decide on the optimum distribution policy to optimize the blood product
inventory system. The optimum solution was provided for a horizon of length, T. However
forecasts for periods further into the future are likely to be in error and of a poorer quality, and to
take this into consideration 'rolling horizon schedules' are used as a common business practice.
In principle, some incremental benefit will be realized by extending the planning horizon
since a greater amount of relevant data is brought into the analysis. The concern here is to
analyze the total benefits derived from longer horizons. "The optimization of finite-horizon
models is backed implicitly by the belief that these solutions will be optimal, or at least very
good, when implemented on a rolling basis" (Baker and Peterson, 1979).
The rolling horizon schedule aimed to split a long horizon of length, T, into several sub-
problems with a forecast window, N, (where N < 7'). The total number of sub-problems would be
T - N + 1.
The algorithm for the rolling schedule is:
1. Begin with t = 0 with yjo known for j = 1 to J.
2. Increment t by 1, and assume that the aggregated released quantity R t and Dt are known
and yjt-i would migrate to yj+i,t'. At t' = t + 1 to t + N - 1 the forecasted values for Rt and
Dtare utilized. Solve for the finite-horizon problem from periodso+N-1, and r cord
only the first period action as period t action.
3. Check to see if t = T- N + 1. If yes, then implement the whole solution, then stop;
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if t T- N + 1, then implement the first solution and return to step 2.
4. Compute the model until the t = T and the objective function (total benefit) is obtained.
4.8.1 A Computational Study
Inventory managers must make decisions daily based on an appropriate model horizon to plan
for the optimal issuing policy. Solutions resulting from a shorter horizon period may be
suboptimal over the long run. This raises the question of how far ahead a forecast the inventory
manager needs to optimize the inventory problem in the long term. The answer is not obvious.
Either the inventory manager may use the actual quantity released R t and actual demand D t only
or include some forecast values of R t and Dt to optimize the inventory, assuming R and D are
known at the beginning.
To investigate rolling horizon schedules, the forecasted and actual quantity released, R t
and demand, D t for 92 periods listed in Appendix C were generated using the forecasting model
of Chapter 3. The first period in the static test was assumed to have actual values of R t and Dr
and the rest of the periods have forecasted values of R t and Dt. The quality of a set of
implemented rolling-horizon decisions is evaluated by comparing a forecast window, N = 1, 2, 5,
7, and 92 for the inventory model with period, T = 92 days using equation 4.11. The concern here
is that the forecast error in the static solution calculated may be suboptimal over the entirety of
the rolled horizons. For example, in N =1, with T = 92, the number of runs R = (T-N+1)= 92
using actual values of R t and D t throughout the 92 runs ; for N = 2, R = 91... and for N = 92, R
=1.
The revenue for filling one unit of demand was $600 for a product at age 3, $550 for a
product at age 4, $500 for a product at age 5, $450 for a product at age 6, $400 for a product at
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age 7, lost sales attract a penalty of $100 per unit due to unrealized revenue and loss of goodwill
from customers, holding one unit in inventory will cost $10 per day, and a unit that has expired
costs $50.
The total benefit or the objective function of equation 4.11 was taken into consideration
to compare the rolling horizon outcomes of N = 1, 2, 5, 7, and 92.
4.8.2 Computational Results
Shewhart (1939) control charts were used to track the forecasting statistics of the quantity
released Rt and demand D t over time and to detect the presence of special causes as explained in
Chapter 3. Special causes result in variation that can be detected and controlled. Common cause
variation, on the other hand, is inherent in the forecasting methodology or process.
A process is in control when only common causes affect the process output. A process is
in control when data points fall within the bounds of the control limits, and the points do not
display any nonrandom patterns.
Each of the eight tests for special causes described in Chapter 3, which detect a specific
pattern in data plotted on the Individuals chart and Moving Range (I-MR) control chart, were
used to evaluate the forecasting error for quantity released R t and demand Dt. The occurrence of
a pattern suggests a special cause for the variation, one that needs to be investigated. The
Upper/Lower control limits are three standard deviations above/below the center line (mean)
respectively.
Figure 4.8 IMR chart for forecast release error.
Figure 4.9 IMR chart for forecast demand/sales error.
Figures 4.8 and 4.9 indicate that there were no data points outside the control limits
exhibiting a nonrandom pattern, suggesting that one could accept results from the forecasting
method. Hence, the rolling horizon method was used for the inventory problem. Using the LP
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inventory model equation 4.11 and the LINGO optimization software the value of the objective
function (Total Benefit) and the average daily total benefit was calculated for N = 1, 2, 5, 7, and
92 as summarized in Figure 4.10.
N Daily Total Benefit Percent
1Day 106,347 99.66%
2Day 106,388 99.70%
5Day 106,484 99.79%
7Day 106,676 99.97%
92Day 106,707 100.00%
Figure 4.10 Rolling horizon results.
N = 92 was compared with a horizon window N = 1, 2, 5, and 7 and the following
percentages 99.66, 99.70, 99.79, and 99.97 were obtained respectively. Even though for N = 1
actual Rt and Dt were used for the calculation, this option generated the least daily total benefit.
It was observed that the objective function increases as the forecast window, N, approaches the
length the horizon length, T, which supports the findings of Baker and Paterson, (1979).
Thus the inventory manager at the blood center would have to use forecast windows N
greater than 1 to achieve better issuing policies.
CHAPTER 5
STOCHASTIC MODEL
5.1 Overview
In Chapter 4 linear programming (LP) was combined with the rolling horizon technique and a
heuristic method was used to solve the inventory management problem. For simplicity, the
released blood quantity Rt and demand Dt had been assumed to be known with certainty.
However, in real life, R t and Dt were not known with certainty. Hence, a situation when R and D
over a given time period are random was considered.
A mathematical model formulated should reflect the questions that the analyst wants
answered about the real system by using analytic methods of mathematics or by simulation
methods. Analytic models are often difficult to build and solve. However, simpler analytic
models can be used to verify the parameters and assumptions of a simulation model. Attempts to
use analytical models to solve such inventory systems usually require so many simplifying
assumptions that the solutions are likely to be inferior or inadequate for implementation.
Simulation, which is a technique that imitates a real-world system operation, can be used
to test a variety of solution methods and models. A major advantage of simulation is its
algorithmic nature, which makes it easier for the non-mathematical audience to understand and
appreciate the model. A static simulation model represents a system at a particular time, for
example the Monte Carlo simulation model. A dynamic simulation model represents a system as
it evolves over time.
The main elements in a simulation analysis are problem formulation, data collection and
analysis, random variable generation, model simulation, and simulation results and analysis.
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5.2 Problem Formulation
The objective is to maximize the social benefit of fulfilling the Single Donor Platelets (SDP)
demand from hospitals. The blood center would have to decide to move fresher products (LIFO
issuing policy — improve customer service), move older products (FIFO — to reduce outdate rate)
or use the so called 'mixed or hybrid' FIFO/LIFO strategy to fulfill demand.
The exogenous (input) variables are the released quantity R and demand D which are
random in character. Parameters are the social benefit (WO, the lost sales penalty due to
unfulfilled demand (P), the holding cost (Hi) for the storage of one unit of inventory for one time
period, the outdate cost (0) for expired products and the issuing policy. Since the released
product Rt and demand Dt take on a finite number of values, they were modeled as discrete
random variables. The system performance measures include the expected Total Benefit, Lost
Sales (or Warning Rate), Average Outdate, and Average Age of products moved to fulfill
demand.
Earlier in Chapter 4 a Linear Programming (LP) method combined with a rolling horizon
schedule and a heuristic method using pure FIFO, pure LIFO or so-called 'mixed' FIFO/LIFO
strategy were established, to solve the inventory problem.
5.3 Data Collection and Analysis
Data used in this study were collected at the New York Blood Center with permission from the
Vice President Core Operations. To limit the scope of the study, the released product Rt and
demand Dt are an aggregate of any of the eight ABO-Rh types of platelets. There is a need to
specify the probability distributions for the input random variables R t and Dt to carry out a
simulation of the inventory system.
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Data collection analysis is a critical step in a discrete time simulation model. One could
specify the historical data distributions by using an empirical distribution based on the historical
data or, using the standard techniques of statistical inference to "fit" a theoretical distribution
(Poisson, Discrete Uniform...) form to the historical data observed and then perform a
hypothesis test to determine goodness-of-fit (Law and Kelton 1982).
Data were collected for 547 days (one and a half years) for both the released product Rt
and the demand Dt. An ANOVA test for each sample for Rt and Dt for each day of the week
indicated that they were significantly different by day. A histogram was used to ascertain the
probability distribution for R and D for each day of the week. The system inputs R and D were
therefore modeled as discrete distributions for a 7-day cycle and for T days for the stochastic
inventory model.
5.4 Random Variable Generation and Model Validation
The random variables R and D are characterized by their probability distributions. The Crystal
Ball® software was used for random variable generation. Figures 5.1 and 5.2 depict the custom
distribution for the R on Sunday (Su) and the demand (Dmd) D, respectively. Crystal Ball®
defined the terms on the custom distribution as "Relative probability meaning the sum of the
probabilities that does not have to add up to 1. So the probability for a given value is
meaningless by itself; it makes sense only in relation to the total relative probability. For
example, if the total relative probability is 3 and the relative probability for a given value is 1,
the value has a probability of 0.33".
Figure 5.1 Discrete frequency distribution for released quantity R.
Figure 5.2 Discrete frequency distribution for demand D.
The Crystal Ball® software uses the multiplicative congruential generator defined by modulo
(231 -1) to generate random variables, which have been found to be efficient (Law and Kelton,
1982). The generator has a period of length 2,147,483,646. This means that the cycle of random
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numbers repeats after several billion trials. Crystal Ball® uses a single Random Number
Generator (RNG) to produce values for all of the assumptions defined in the excel spreadsheet
model. The software then uses a sampling method known as Latin hypercube sampling, to select
the Rt and Dt values.
5.5 Simulation
For the simulation exercise the same (R, D) sequence is used as input for the Linear
Programming (LP) with rolling horizon and the heuristic ( `mixed' FIFO/LIFO) methods.
Random variables for (R, D)t were generated using the Crystal Ball software for cycle = 7, and T
= 365 days. The average daily total benefit was used as a performance measure to compare the
LP - based rolling horizon with forecast window, N and the heuristic 'mixed' policy methods.
The flow chart of the stochastic inventory simulation model is presented in Figure 5.3.
Figure 5.3 Flow chart of stochastic inventory simulation model.
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The random variables generated for (R, Mt for T days were used as inputs for the LP with
rolling horizon or 'mixed' FIFO/LIFO  policy method, for calculating the Total Benefit, Outdate
Rate and Average Age of products shipped to fulfill demand D.
5.5.1 For the Linear Programming (LP) with Rolling Horizon Solution
The LP with rolling-horizon schedule could have many variants, with different look-ahead
windows of length, N. The Rolling horizon schedule was split into several sub-problems with a
forecast or look-ahead window length, N, (where N < 7) for the entire horizon, 7'. The total
number of sub-problems would be T-N +1 for each forecast window, N. Thus a finite horizon
multi-period model was solved and the first period's decision only was implemented. The
quantity of blood product at age j used to fill demand on day t (Xi) was recorded for each run.
For the Linear Programming (LP) with rolling horizon schedule method equation 4.11 was used
with forecast window length, N = 1, 3, 5, 7, and 9 days.
5.5.2 For the Heuristic Model
The same data used for the LP with rolling-horizon schedule model as described above were
used for the heuristic model. The 'mixed' FIFO/LIFO issuing policy at ten percent intervals was
used and the performance measures recorded.
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5.6 Stochastic Empirical Study
A blood center would have to decide the way to fulfill daily demand of blood products.
Historical data were provided for 50 months for both the daily released quantity R and demand
D. There are three groups of revenue schedule for fulfilling demand of blood products.
The revenue schedule for filling one unit of demand was: $600 for a product at age 3,
$550 for a product at age 4, $500 for a product at age 5, $450 for a product at age 6, $400 for a
product at age 7 for Group A Samples; $520 for a product at age 3, $510 for a product at age 4,
$500 for a product at age 5, $490 for a product at age 6, $480 for a product at age 7 for Group B
Samples; and $500 for a product at age 3, $500 for a product at age 4, $500 for a product at age
5, $500 for a product at age 6, $500 for a product at age 7 for Group C Samples. The lost sales
attract a penalty $100 per unit due to unrealized revenue and loss of goodwill from customers,
holding one unit in inventory will cost $10 per day, and a unit that has expired costs $50 for
Groups A, B, and C Samples.
The objective is to determine how the blood center can maximize average daily total
benefit (revenue less lost sale, outdate, and holding cost) by fulfilling SDP demand using the
released quantity R, demand D, and the revenue schedule for Groups A, B, and C, and make
comparison between the heuristic model with 'mixed' FIFO/LIFO issuing policy and the LP
based rolling horizon schedule with forecast window, N = 1, 3, 5, 7, and 9 days.
Stochastic Empirical Results and Analysis
In the empirical study the heuristic model was compared with the 'mixed' FIFO/LIFO issuing
policy and the LP based rolling horizon schedule with forecast windows, N = 1, 3, 5, 7, and 9
days and their impact on the inventory problem.
The primary concern was to compare each average total benefit. Tables 5.04, 5.05 and
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5.06 display the average daily total benefit, the standard deviation and the percent of the
maximum average daily total benefit for group samples A, B, and C, respectively.
Table 5.4 Average Daily Total and Standard Deviation (Group A)
Method Average Daily Total Benefit Std. Dev Percent
N=1 $96,829 5763 94.2%
N=3 $100,584 2384 97.8%
N=5 $102,240 744 99.4%
N=7 $102,756 718 99.9%
N=9 $102,808 760
FIFO=0/LIFO=100 $101,868 846 99.1%
FIFO=10/LIFO=90 $100,979 796 98.2%
FIFO=20/LIFO=80 $99,112 1186 96.4%
FIFO=30/LIFO=70 $96,488 1609 93.9%
FIFO=40/LIFO=60 $93,172 1870 90.6%
FIFO=50/LIFO=50 $89,455 2044 87.0%
FIFO=60/LIFO=40 $85,721 2253 83.4%
FIFO=70/LIFO=30 $81,887 2468 79.7%
FIFO=80/LIFO=20 $78,113 2831 76.0%
FIFO=90/LIFO=10 $74,555 3699 72.5%
FIFO=100/LIFO=0 $71,197 4658 69.3%
The results of Table 5.4 indicate that the LP with rolling horizon schedule and a forecast
window length, N = 9 for Group A produced the maximum average daily total benefit
($102,808). This value was used as a base to compare the other methods and the results are
shown in dollar amount and as a percent of the maximum. Thus, the results from the LP with a
rolling horizon and forecast window length, N = 1, 5, 7, 9 and from the heuristic 'mixed' policy
with FIFO = 0/LIFO = 100, 10/90, 20/80, 30/70, 40/60, 50/50, 60/40, 70/30, 80/20, 90/10, and
100/0, were respectively 94.2, 97.8, 99.4, 99.9, 100, 99.1, 98.2, 96.4, 93.9, 90.6, 87.0, 83.4,
79.7, 76.0, 72.5, and 69.3, percent of the optimum.
The one way analysis of variance (ANOVA) F test was used on each of the 16
combinations (LP with rolling horizon and forecast window length, N = 1, 3, 5, 7, or 9;
FIFO=0/LIFO=100, 10/90, 20/80, 30/70, 40/60, 50/50, 60/40, 70/30, 80/20, 90/10, and 100/0).
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Figure 5.7 shows the comparison of the heuristic and the LP with rolling horizon methods using
the ANOVA test.
Figure 5.7 Comparison of heuristic and LP-rolling horizon methods.
The null hypothesis was H o : the average daily total benefit for the 16 combinations was
identical for all methods, and the alternative hypothesis was H 1 : the average total benefit values
for the 16 combinations are not all identical. The ANOVA F test was statistically significant with
a p-value less than 0.0005 indicating that there was sufficient evidence that not all the average
daily total benefits were equal when the confidence level was set at 95 percent. Hence the null
hypothesis was rejected and concluded that there was strong statistical evidence that the average
daily total benefits are not equal.
A similar analysis was conducted for Group B and C revenue schedules as indicated in
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Table 5.5 and 5.6. In both cases the LP with rolling horizon schedule and a forecast window
length, N = 9 produced the maximum average daily total benefit.
Table 5.5 Average Daily Total and Standard Deviation (Group B)
Method Average Daily Total Benefit Std. Dev Percent
N=1 $88,398 1470 97.1%
N=3 $89,679 698 98.5%
N=5 $89,936 863 98.8%
N=7 $90,546 593 99.4%
N=9 $91,048 820
FIFO=0/LIFO=100 $89,263 716 98.0%
FIFO=10/LIFO=90 $89,721 645 98.5%
FIFO=20/LIFO=80 $89,550 896 98.4%
FIFO=30/LIFO=70 $88,934 1120 97.7%
FIFO=40/LIFO=60 $87,970 1267 96.6%
FIFO=50/LIFO=50 $86,800 1335 95.3%
FIFO=60/LIFO=40 $85,591 1423 94.0%
FIFO=70/LIFO=30 $84,339 1526 92.6%
FIFO=80/LIFO=20 $83,105 1678 91.3%
FIFO=90/LIF0=10 $81,942 1995 90.0%
FIFO=100/LIFO=0 $80,833 2309 88.8%
Table 5.6 Average Daily Total and Standard Deviation (Group C)
Method Average Daily Total Benefit Std. Dev Percent
N=1 $83,858 2497 95.0%
N=3 $83,965 2452 95.1%
N=5 $86,462 1380 97.9%
N=7 $87,211 1300 98.8%
N=9 $88,273 1223
FIFO=0/LIFO=100 $86,042 702 97.5%
FIFO=10/LIFO=90 $86,928 715 98.5%
FIFO=20/LIFO=80 $87,245 1187 98.8%
FIFO=30/LIFO=70 $87,145 1472 98.7%
FIFO=40/LIFO=60 $86,803 1673 98.3%
FIFO=50/LIFO=50 $86,301 1755 97.8%
FIFO=60/LIFO=40 $85,771 1841 97.2%
FIFO=70/LIFO=30 $85,196 1953 96.5%
FIFO=80/LIFO=20 $84,643 2102 95.9%
FIFO=90/LIFO=10 $84,161 2364 95.3%
FIFO=100/LIFO=0 $83,686 2588 94.8%
For the heuristic model it was observed that for Group A, the maximum average total benefit was
recorded when FIFO=0/LIFO=100 or pure LIFO. The maximum average total benefit for Group
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B was recorded when FIFO=10/LIFO=90, and for Group C when FIFO=20/LIFO=80. It was
observed that the near optimal for the heuristic model with Group A revenue schedule was at
FIFO=0/LIFO=100 or pure LIFO, Group B revenue schedule was at F IFO=10/LIFO=90, and
Group C revenue schedule was at FIFO=20/LIFO=80. For the heuristic model, the revenue
schedule influenced the near optimal 'mixed' FIFO/LIFO policy.
5.7 Case Study II
A blood center has to determine the way to fulfill daily demand of blood products. Historical
data for 78 weeks were used for both the daily released quantity R and demand D. (Tetteh and
Baldwin, 2006)
The blood center used to produce Single Donor Platelets (SDPs) that expire on the fifth
day (5 Day) after collection. However, the blood center in collaboration with Gambro BCT has
been licensed by the Food and Drug Administration (FDA) to produce SDPs that expire on the
seventh day (7 Day) of collection.
The revenue for filling one unit of a 5 - Day or a 7 - Day platelet is presented in Table
5.7.
Table 5.7 Revenue Schedule for 5 - Day and 7 - Day Platelets
Age 3 Age 4 Age 5 Age 6 	 Age 7
5 Day Platelet - Group A $600 $500 $400
7 Day Platelet - Group A $600 $550 $500 $4501 	 $400
5 Day Platelet - Group C $500 $500 $500
7 Day Platelet - Group C $500 $500 $500 $5001 	 $500
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The lost sales attract a penalty $100 per unit due to unrealized revenue and loss of goodwill from
customers, holding one unit in inventory will cost $10 per day, and a unit that has expired costs
$50.
The objective is to develop a simulation model comparing the 5 - Day and 7 - Day SDPs
in terms of inventory management to:
(1) Determine how the blood center can maximize daily welfare or total benefit (revenue
less lost sale, outdate, and holding cost) by fulfilling SDP demand using the released quantity
R and demand D.
(2) Calculate the outdate rate, and the average age of SDPs shipped to hospital blood banks.
5.7.1 Stochastic Approach
Based on the given historical data, random variables for (R, D)1 were generated and identical
distributions were used with the 5 - Day and the 7 - Day LP with rolling horizon method.
In section 5.6 it was shown that an LP model with rolling horizon forecast window
length, N = 9 would achieve a near optimal issuing policy for the inventory problem. Hence this
method was used for both the 5 - Day and 7 - Day models in the simulation. Using the
parameters given in the case study the performance measures of interest namely, average daily
total benefit, average outdate rate, and the average age of products shipped to the hospital blood
bank was obtained.
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5.7.2 Simulation Results
Table 5.8 displays the simulated result of the 7 - Day and the 5 - Day models for the average
daily total benefit and their standard deviations, the average outdate rate and the average age of
products shipped to the hospitals for the Group A and C revenue schedules.
Table 5.8 Comparison of the 5 Day and 7 Day Models
Variable Average Daily Total Benefit Stdev Average Outdate Average Age
7-Day Group A $102,750 $661 7.00% 3.31
5-Day Group A $100,421 $687 7.54% 3.26
7-Day Group C $87,726 $670 7.00% 3.31
5-Day Group C $88,340 $727 6.59% 3.41
5.7.3 Average Daily Total Benefit
To compare the statistical significance of the average daily total benefit of the 7 - Day and the 5 -
Day models a two sample T-Test was employed. Figures 5.9 and 5.10 show the graph for the
daily benefit for the 7 - Day and the 5 - Day models.
Figure 5.9 Average daily total benefit — 7 - Day vs, 5  - Day Group A.
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Figure 5.10 Average daily total benefit —7 - Day vs. 5 - Day Group C.
The hypotheses in terms of the average daily total benefit for the 7 - Day model, p7, and
the average daily total benefit for the 5 - Day model, p 5 were:
Ho: [17 = ms
Ha : 17 	 15
For the revenue schedule of Group A, a p-value of 0.0005 from the two-sample T-Test
with a 95 percent confidence level suggested the null hypothesis could be rejected. Thus, the
mean average daily total benefit for the 7 - Day model, $102,750, was not equivalent to the 5
Day model of S 100,421. The 7 - Day model will achieve a noticeably greater average daily total
benefit.
For the revenue schedule of Group C, a p-value of 0.165 from the two-sample T-Test
with a 95 percent confidence level suggested the null hypothesis could not be rejected. Thus, the
mean average daily total benefit for the 7 - Day model, $87,726 was equivalent to the 5 - Day
model of $88,340. The holding and outdate costs could be the reason the average daily total
benefit for the 7 - Day model with revenue schedule Group C was slightly lower than the 5 - Day
model. The results indicate that the significance of the average daily total benefit for 7 - Day and
5 - Day platelet models depend on the revenue schedule.
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5.7.4 Average Outdate Rate
Figure 5.11 shows the 7 —Day average outdate rate. For the Group A revenue schedule, the
average outdate rates were 7.00 and 7.50 percent for the 7 - Day and 5 - Day models
respectively, and were not statistically significant.
Figure 5.11 7 Day average outdate rate.
Also for the Group C revenue schedule, the average outdate rates were 7.00 and 6.59 percent for
the 7 Day and 5 Day model respectively, and were not statistically significant.
5.7.5 Average Age of Products Shipped
The average age of products shipped to hospital blood banks for both the 7 Day and 5 Day
models for Groups A and C were around 3.30 days, and were equivalent. However, for the 7 -
Day model an average age of 3.31 days indicates 88.56 hours remaining for the product to
expire. Similarly, for the 5 - Day model an average age of 3.26 days indicates 41.76 hours
remaining for the product to expire. Thus, the 7 - Day model would allow a blood center to
58
distribute more 'fresher' SDP products.
5.7.6 Discussion
Prior to the introduction of the 7 - Day platelets to the hospital blood banks, a marketing survey
indicated the following:
(1) While hospitals "value" the reduced outdating and better inventory management
associated with 7-Day platelets, they demonstrated no willingness to pay extra for
increased shelf life.
(2) Reduced outdating may benefit smaller hospitals rather than larger ones as smaller
hospitals generally have higher outdating.
(3) The general practice within hospitals is to release the oldest (i.e., closest to expiration
date) product first with exceptions for special cases (e.g., pediatric needs)
When a blood center distributed only 5 - Day platelets, 50 percent of the products had a
shelf-life of 45 hours remaining. With the introduction of the 7 - Day platelets, 50 percent of the
products had over 75 hours remaining.
The simulation results indicate that the blood center could distribute 'fresher' platelets
and not significantly affect their outdate rate or ability to cover shortages. The 7 - Day platelet
introduction by Gambro BCT would reduce hospital banks' outdates by having 'fresher'
products distributed to them by the blood center.
CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS FOR FURTHER STUDIES
6.1 Conclusions
Forecasting Blood Supply and Demand
A linear regression model was used as a forecasting method for the blood supply prediction and a
moving average for the blood demand. The ImR computer plots used to verify that the
forecasting method results in are appropriate in Chapter 3 indicated no out-of-control or
unpredictable conditions for the forecasted released products and sales. Thus, there are no special
causes. One could conclude that the methodology was appropriately predicting the quantity of
SDP products to be released and sales (demand) for each period.
Blood Inventory Management
A heuristic and an LP with rolling horizon schedule methods were used to solve the blood
inventory problem. The heuristic method implemented on a Microsoft Excel spreadsheet
formulation (Appendix F) with data provided for the released quantities R t and demand Dt,
considered that the issuing policy was FIFO from 0% to 100%. The empirical study in Chapter 5
suggested that an LP with rolling horizon forecast windows within the ranges of 5 to 9 days
could achieve a near optimal solution to the inventory problem. It was observed that the near
optimal for the heuristic model with a Group A revenue schedule was at FIFO=0/LIFO=100 or
pure LIFO. The Group B revenue schedule near optimum was at FIFO=10/LIFO=90, and the
Group C revenue schedule near optimum was at FIFO=20/LIFO=80. For the heuristic model, the
revenue schedule influenced the near optimal 'mixed' FIFO/LIFO policy.
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6.2 Further Studies
Further studies on the forecasting and optimal allocation of blood products (with special
reference to Single Donor Platelets) could focus on the following: (1) blood supply (collection
and production) and demand (2) pricing of blood products.
Blood Supply and Demand
Based on the historical data analysis, it was assumed that blood supply (collection and
production) was stable and similar throughout the year. A similar analysis of blood demand from
historical data exhibited the same characteristics, hence demand was assumed to be constant
throughout the year. Future studies could investigate how the limited control strategies of the
inventory manager affect blood supply (collection) and demand. Other prediction models could
be used if blood supply and demand were not constant.
Pricing of Blood Products
For the heuristic model, it was observed that the revenue schedule influenced the near optimal
`mixed' FIFO/LIFO policy. Even though pricing of blood products is not highly regulated, blood
centers need to recover processing and replacement costs.
It has been the philosophy of the American Red Cross (ARC) that the blood supply is a
"community" responsibility, and patients' should not pay a replacement fee (Johnson 1977). Just
as most firms face competition for customers, most nonprofit blood suppliers face competition
for the resources and support they need. As with any business, a nonprofit organization must take
in as much money as it spends or it will not survive. However, a nonprofit institution may not
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measure "profit" in the same terms as a firm. It is difficult to evaluate the benefits of blood
supply to the society relative to what it costs.
Blood centers operate as non-profit organizations, and will charge a service fee to recover
costs for processing blood after collection, laboratory testing, storage and distribution.
Quantitative cost measurements of the inventory system of a blood center are difficult, since the
estimation of the benefits (or costs) resulting from the availability or lack of platelets just-in-time
for an emergency transfusion is very subjective. It will not be an easy task to place a value on a
life saved through a needed platelet transfusion. The pricing of blood products remains an open
research question.
APPENDIX A
FORECAST OUTPUT OF QUANTITY RELEASE (R)
AND DEMAND/SALES (D) FOR JULY 2006
Actual and forecasted released products and the deviations are depicted in Table A.1.
Table A.1 Actual and Forecasted Released Products/Sales
Date Actual Rel Forecast Rel Deviation Actual Sale, Fore. Sales Deviation
7/1/2006 237 247 -10 147 165 -18
7/2/2006 248 269 -21 146 132 14
7/3/2006 200 222 -22 183 220 -37
7/4/2006 126 122 4 184 174 10
7/5/2006 270 299 -29 152 181 -29
7/6/2006 0 0 0 184 207 -23
7/7/2006 202 239 -37 180 185 -5
7/8/2006 260 290 -30 190 158 32
7/9/2006 274 271 3 185 141 44
7/10/2006 195 229 -34 176 217 -41
7/11/2006 52 63 -11 234 208 26
7/12/2006 258 266 -8 154 182 -28
7/13/2006 219 205 14 229 197 32
7/14/2006 173 129 44 156 181 -25
7/15/2006 208 219 -11 142 171 -29
7/16/2006 222 220 2 168 158 10
7/17/2006 207 166 41 183 203 -20
7/18/2006 55 45 10 162 193 -31
7/19/2006 167 159 8 214 197 17
7/20/2006 220 184 36 188 223 -35
7/21/2006 202 165 37 190 179 11
7/22/2006 182 188 -6 148 166 -18
7/23/2006 170 159 11 167 165 2
7/24/2006 236 240 -4 222 184 38
7/25/2006 79 45 34 154 192 -38
7/26/2006 237 190 47 208 167 41
7/27/2006 205 184 21 183 216 -33
7/28/2006 213 195 18 182 183 -1
7/29/2006 193 200 -7 168 166 2
7/30/2006 226 194 32 144 168 -24
7/31/2006 239 205 34 193 193 0
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APPENDIX B
CONSTANTS FOR CONTROL CHARTS
Table B.1 Constants for Control Charts.
Subgroup
Size
A2 for
Median
ChartsN A2 d2 D3 D4 C4 B3 B4 E2 A4 D5 D6
2 1.880 1.128 - 3.267 2.659 0.798 - 3.267 2.660 1.880 2.224 - 3.865
3 1.023 1.693 - 2.574 1.954 0.866 - 2.568 1.772 1.187 1.091 - 2.745
4 0.729 2.059 - 2.282 1.628 0.921 - 2.266 1.457 0.796 0.758 - 2.375
5 0.577 2.326 - 2.114 1.427 0.940 - 2.089 1.290 0.691 0.594 - 2.179
6 0.483 2.534 - 2.004 1.287 0.952 0.030 1.970 1.184 0.548 0.495 - 2.055
7 0.419 2.704 0.076 1.924 1.182 0.959 0.118 1.882 1.109 0.508 0.429 0.078 1.967
8 0.373 2.847 0.136 1.864 1.099 0.965 0.185 1.815 1.054 0.433 0.380 0.139 1.901
9 0.337 2.970 0.184 1.816 1.032 0.969 0.239 1.761 1.010 0.412 0.343 0.187 1.850
10 0.308 3.078 0.223 1.777 0.975 0.973 0.284 1.716 0.975 0.362 0.314 0.227 1.809
Source: Benhow, D.W., Kubiak, T.M., "The Certified Six Sigma Black Belt," ASQ Quality Press, Milwaukee,
Wisconsin, 2005.
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APPENDIX C
92 DAY FORECAST AND ACTUAL QUANTITY RELEASE (R) AND DEMAND/SALES
(D)
Table E.1 92 Day Forecast and Actual Quantity Release (R) and Demand/Sales (D)
Day ForeRel ActRel RError ForeDem ActDem DError Day ForeRel ActRel RError ForeDem ActDem DError
1 230 259 29 165 174 9 47 197 187 -10 196 169 -27
2 244 267 23 188 217 29 48 241 228 -13 168 151 -17
3 55 54 -1 223 194 -29 49 218 214 -4 164 145 -19
4 213 205 -8 188 142 -46 50 228 214 -14 239 216 -23
5 182 247 65 204 244 40 51 46 71 25 195 203 8
6 207 214 7 207 186 -21 52 179 172 -7 224 219 -5
7 214 234 20 156 151 -5 53 190 220 30 203 165 -38
8 183 246 63 166 137 -29 54 202 187 -15 188 164 -24
9 209 246 37 209 238 29 55 206 160 -46 162 149 -13
10 48 86 38 207 196 -11 56 240 251 11 155 174 19
11 211 181 -30 180 185 5 57 223 203 -20 239 218 -21
12 186 168 -18 207 182 -25 58 61 112 51 203 209 6
13 164 191 27 208 158 -50 59 150 183 33 208 208 0
14 240 234 -6 154 149 -5 60 194 208 14 196 174 -22
15 228 233 5 160 153 -7 61  202 188 -14 185 166 -19
16 202 210 8 226 238 12 62 184 186 2 162 164 2
17 44 50 6 202 230 28 63 187 183 -4 159 158 -1
18 207 232 25 180 178 -2 64 218 261 43 228 235 7
19 173 194 21 216 189 -27 65 52 84 32 207 179 -28
20 214 234 20 194 184 -10 66 191 233 42 238 193 -45
21 222 226 4 157 164 7 67 181 203 22 185 164 -21
22 213 238 25 161 162 1 68 190 182 -8 180 123 -57
23 256 253 -3 241 209 -32 69 256 306 50 161 136 -25
24 57 68 11 215 170 -45 70 320 362 42 158 123 -35
25 194 162 -32 195 184 -11 71 261 293 32 233 184, -49
26 201 214 13 211 196 -15 72 65 94 29 182 167 -15
27 195 193 -2 198 163 -35 73 179 172 -7 197 228 31
28 228 216 -12 163 185 22 74 229 236 7 167 147 -20
29 219 259 40 170 158 -12 75 255 223 -32 186 	 226 40
30 223 234 11 235 263 28 76 244 226 -18 165 177 12
31 54 70 16 204 191 -13 77 332 307 -25 154 175 21
32 200 214 14 187 188 1 78 230 232 2 216 201 -15
33 206 222 16 212 217 5 79 68 69 1 195 196 1
34 182 214 32 190 176 -14 80 213 205 -8 188 142 -46
35 220 190 -30 169 145 -24 81 160 180 20 177 209 32
36 218 209 -9 163 162 -1 82 150 164 14 188 175 -13
37 220 219 -1 245 202 -43 83 234 258 24 165 152 -13
38 53 84 31 204 180 -24 84 226 285 59 163 162 -1
39 231 238 7 197 228 31 85 210 237 27 214 266 52
40 226 246 20 203 145 -58 86 48 78 30 198 232 34
41 262 314 52 188 183 -5 87 227 220 -7 209 176 -33
42 313 344 31 168 155 -13 88 194 196 2 184 197 13
43 242 238 -4 234 252 18 89 183 218 35 190 179 -11
44 72 75 3 199 198 -1 90 193 197 4 164 176 12
45 258 254 -4 209 247 38 91 186 243 57 160 172 12
46 232 230 -2 195 228 33 92 235 273 38 231 250 19
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APPENDIX D
LINGO MODEL
Figure D.1 Contains the objects or sets that define the problem are Days, Time, Release,
Demand, Quantity moved to fill demand (x3, x4, x5, x6, x7), Products Remaining in Inventory
(y3, y4., y5, y6, y7), Outdate, Total in Inventory, and Lost sale.
MODEL:
SETS:
DAYS/D1..D30/:TIME,REL,DEM,X3,X4,X5,X6,X7,Y3,Y4,Y5,Y6,Y7,0,L;
ENDSETS
MAX=@SUM(DAYS:
550*(X3+X4+X5+X6+X7)-10*(Y3+Y4+Y5+Y6+Y7)-550*L -50*0 );
@FOR(DAYS(I) ITIME(I)#GT#1:
Y3(I)+X3(I)=REL(I);
Y4(I)+X4(I)=Y3(I-1);
Y5(I)+X5(I)=Y4(I-1);
Y6(I)+X6(I)=Y5(I-1);
Y7(I)+X7(I)=Y6(I-1);
0(I)=Y7(I-1);
X3(I)+X4(I)+X5(I)+X6(I)+X7(I)+L(I)=DEM(I););
Y3(1)+X3(1)=REL(1);
Y4(1)+X4(1)=106;
Y5(1)+X5(1)=106;
Y6(1)+X6(1)=106;
Y7(1)+X7(1)=106;
O(1)=0;
X3(1)+X4(1)+X5(1)+X6(1)+X7(1)+L(1)=DEM(1);
DATA:
REL=193 	 149 	 151 	 169 	 115 	 23 	 174 	 164 	 132 	 155 	 189 	 133
41 	 169 	 179 	 143 	 169 	 201 	 147 	 67 	 197 	 190 	 135 	 169
198 	 146 	 71 	 184 	 171 	 176;
DEM=143 	 94 	 104 	 123 	 125 	 170 	 116 	 211 	 186 	 96 	 116 	 166
138 	 191 	 171 	 120 	 121 	 115 	 185 	 145 	 179 	 146 	 150 	 116
112 	 170 	 132 	 187 	 188 	 140;
TIME=1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,
28, 29, 30;
ENDDATA
END
Figure D.1 Lingo Model for solving the Inventory Problem.
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APPENDIX E
LINGO OUTPUT
Table E.1 LINGO Output for the Inventory Problem.
Global optimal solution found.
Objective value: 2334590
Total 	 solver iterations: 	 115
Time Rel Dem X3 X4 X5 X6 X7 Y3 Y4 Y6 Y6 Y7 0 L
1 193 143 143 0 0 0 0 50 106 106 106 106 0 0
2 149 94 94 0 0 0 0 55 50 106 106 106 106 0
3 151 104 82 0 0 22 0 69 55 50 84 106 106 0
4 169 123 83 0 0 40 0 86  69 55 10 84 106 0
5 115 125 115 0 0 0 10 0 86 69 55 0 84 0
6 23 170 23 0 39 53 55 0 0 	 47 16 0 0 0
7 174 116 100 0 0 0 16 74 0 0 47 0 0 0
8 164 211 164 0 0 0 47 0 74 0 0 0 0 0
9 132 186 132 0 54 0 0 0 0_ 20 0 0 0 0
10 155 96 96 0 0 0 0 59 0 0 20 0 0 0
11 189 116 59 37 0 0 20 130 22 0 0 0 0 0
12 133 166 133 33 0 0 0 0 97 22 0 0 0 0
13 41 138 41 0 97 0 0 0 0_ 0 22 0 0 0
14 169 191 169 0 0 0 22 0 0 0 0 0 0 0
15 179 171 171 0 0 0 0 8 0 0 0 0 0 0
16 143 120 120 0 0 0 0 23 8 0 0 0 0 0
17 169 121 121 0 0 0 0 48 23 8 0 0 0 0
18 201 115 115 0 0 0 0 86 48 23 8 0 0 0
19 147 185 147 38 0 0 0 0 48 48 23 8 0 0
20 67 145 67 0 48 30 0 0 0 0 18 23 8 0
21 197 179 179 0 0 0 0 18 0 0 0 18 23 0
22 190 146 141 5 0 0 0 49 13 0 0 0 18 0
23 135 150 101 49 0 0 0 34 0 13 0 0 0 0
24 169 116 82 34 0 0 0 87 0 0 13 0 0 0
25 198 112 28 84 0 0 0 170 3 0 0 13 0 0
26 146 170 0 170 0 0 0 146 0 3 0 0 13 0
27 71 132 3 129 0 0 0 68  17 0 3 0 0 0
28 184 187 184 0 0 0 3 0 68 17 0 0 0 0
29 171 188 171 0 0 17 0 0 0  68 0 0 0 0
30 176 140 140 0 0 0 0 36 0 0 68 0 0 0
Total r 4500 4356 3204 579 238 162 173 1296 787 655 599 464 464 0
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APPENDIX F
HEURISTIC METHOD USING MICROSOFT EXCEL
Figure F.1 Heuristic Method using Microsoft Excel.
Figure F.1 Heuristic Method using Microsoft Excel.
To critically examine the issuing policy for the 5-day platelet model, set the following
headings in a spreadsheet as depicted in Figure 4.07: Day (cell A23), Released Quantity (cell
B23), Beginning Inventory with Ages 3, 4, 5 (cells D23-F23), Demand (cell G23), FIFO % (cells
I23-K23), LIFO% (cells M23-O23), After FIFO '(cells Q23-S23), After LIFO (cells T23-V23),
Proportions (W23-Z23), Ending Balance (cells AA23-AC23), Age of Products Shipped (cells
AE23-AG23), Average Age (cell AH23), Lost Sale (cell AI23), Outdate (cell AJ23), Warning
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Days (cell AK 23). The Day heading column was filled through out the period (365 days). To
illustrate the movement of platelets into the system, the Released Quantity represents the
aggregate platelets released every morning after collection and laboratory testing for two days;
this enters the Beginning Inventory as Age 3. Age 4 in cell E25 was obtained from cell AA24-
the Ending Balance on the previous day. The Demand was the aggregate demand from the data
given. The FIFO policy indicates that Age 5 platelets would leave the system first, then Age 4,
and Age 3 in that order. The LIFO policy was the reverse.
For 14114O Part % in cell J25 type the formula =MAX (0, IF (J24 +K24>=L24, 124,
IF(J24+K24< L24, 124 + J24 +K24-24, 124))); for LIFO Part % in cell N25 enter
=MAX(0,IF(M24>=P24,M24-P24, IF (M24 < P24, 0, M24))); for After 14114O Age 3 in cell
Q25 "=IF(SUM(R25:S25)>0,D25, IF(D25 >$L25-E25-F25,D25+E25+F25-$L25,0))"; for
After LIFO Age 3 in cell T25 "=IF(Q25>$P25,Q25-$P25,0)"; for Proportions (Remaining) in
cell W25 "=H25-(SUM(D25:F25)-SUM(T25:V25))";for Ending Balance in cell AA25
"=MAX(0,ROUND(T25-(W25*X25),0))"; for Products Shipped Age 3 in cell AE25 "=D25 -
AA25";for Average Age in cell AH25 "=IF (SUM(AE25:AG25) =0, 0, SUMPRODUCT
($AE$23:$AG$23, AE25:AG25) /SUM(AE25:AG25))"; for Lost Sales in cell AI25
"=IF(SUM(D25:F25)<H25,H25-SUM(D25:F25),0)"; for Outdate in cell AJ25 "=AC25", the
same as the Ending Balance for Age 5; for Warning Days in cell AK25
"=1F(SUM(D25:F25)<$D$9*$E$4,1,0)".
The Lost Sale occurs when the total platelets in the Beginning Inventory are less than the
aggregate Demand for the day; The Outdate occurs when a product at Age 5 was not shipped the
same day; The Warning Level was triggered when the total platelets in the Beginning Inventory
was less than 125 percent of the annual average demand. FIFO, LIFO policies were varied from
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0 to 100 percent and the impact on Lost Sale, Outdate, and Warning Levels were monitored.
FIFO and LIFO policies were held at 50 percent and the Demand was varied to measure the
impact.
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APPENDIX G
FACTORS WITH LEVELS FOR DOE ON OBJECTIVE FUNCTION
Table G.1 Factors with Levels for DOE on Objective Function
Pattern Benefit Hold Lost Outdate T. Benefit
2232 L2 L2 L3 L2 1038794
3231 L3 L2 L3 L1 1139770
2223 L2 L2 L2 L3 1437795
3333 L3 L3 L3 L3 1130165
2333 L2 L3 L3 L3 1029190
1333 L1 L3 L3 L3 625290
3111 L3 L1 L1 L1 1865654
2132 L2 L1 L3 L2 1046479
1232 L1 1.2 L3 L2 634895
1231 L1 L2 L3 L1 634895
1131 L1 L1 L3 L1 642579
2121 L2 L1 L2 L1 1445479
3113 L3 L1 L1 L3 1865654
1132 L1 L1 L3 L2 642579
3121 L3 L1 L2 L1 1546454
3123 L3 L1 L2 L3 1546454
3112 L3 L1 L1 L2 1865654
1322 L1 L3 L2 L2 1024290
2311 L2 L3 L1 L1 1747390
1221 L1 L2 L2 L1 1033895
2222 L2 L2 L2 L2 1437795
2231 L2 L2 L3 L1 1038795
2131 L2 L1 L3 L1 1046479
3133 L3 L1 L3 L3 1147454
3321 L3 L3 L2 L1 1529165
3132 L3 L1 L3 12 1147454
2133 L2 L1 L3 L3 1046479
1211 L1 L2 L1 L1 1353095
1331 L1 L3 L3 L1 625290
2233 L2 L2 L3 L3 1038795
2321 L2 L3 L2 L1 1428190
3311 L3 L3 L1 L1 1747390
1222 L1 L2 L2 L2 1033895
2221 L2 L2 L2 L1 1437795
1311 L1 L3 L1 L1 1343490
3213 L3 L2 L1 L3 1857970
3322 L3 L3 L2 L2 1529165
1212 L1 L2 L1 L2 1353095
1313 L1 L3 L1 L3 1343490
2122 L2 L1 L2 L2 1445479
2312 L2 L3 L1 L2 1747390
Pattern Benefit Hold Lost Outdate T. Benefit
3332 L3 L3 L3 L2 1130165
3232 L3 L2 L3 L2 1139770
1121 L1 L1 L2 L1 1041579
3313 L3 L3 L1 L3 1848365
1133 L1 L1 L3 L3 642579
2322 L2 L3 L2 L2 1428190
2112 L2 L1 L1 L2 1764679
1122 L1 L1 L2 L2 1041579
2323 L2 L3 L2 L3 1428190
1223 L1 L2 L2 L3 1033895
2212 L2 L2 L1 L2 1756995
1321 L1 L3 L2 L1 1024290
2332 L2 L3 L3 L2 1029190
3223 L3 L2 L2 L3 1538770
2213 L2 L2 L1 L3 1756995
3312 L3 L3 L1 L2 1848365
3212 L3 L2 L1 L2 1857970
3122 L3 L1 L2 L2 1546454
1113 L1 L1 L1 L3 1360779
1213 L1 L2 L1 L3 1353095
1123 L1 L1 L2 L3 1041579
3222 L3 L2 L2 L2 1538770
3331 L3 L3 L3 L1 1130165
2313 L2 L3 L1 L3 1848365
3211 L3 L2 L1 L1 1857970
1332 L1 L3 L3 L2 625290
1111 L1 L1 L1 L1 1360779
2211 L2 L2 L1 L1 1756995
1233 L1 L2 L3 L3 634895
1312 L1 L3 L1 L2 1343490
2113 L2 L1 L1 L3 1764679
2331 L2 L3 L3 L1 1029190
3323 L3 L3 L2 L3 1529165
2123 L2 L1 L2 L3 1445479
3233 L3 L2 L3 L3 1139770
3221 L3 L2 L2 L1 1538770
1112 L1 L1 L1 L2 1360779
1323 L1 L3 L2 L3 1024290
3131 L3 L1 L3 L1 1147454
2111 L2 L1 L1 L1 1764679
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